1. Home
  2. LYB vs VTRS Comparison

LYB vs VTRS Comparison

Compare LYB & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LyondellBasell Industries NV (Netherlands)

LYB

LyondellBasell Industries NV (Netherlands)

N/A

Current Price

$64.77

Market Cap

17.2B

Sector

Industrials

ML Signal

N/A

Logo Viatris Inc.

VTRS

Viatris Inc.

N/A

Current Price

$16.95

Market Cap

18.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LYB
VTRS
Founded
1955
1961
Country
United Kingdom
United States
Employees
N/A
30000
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
18.7B
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
LYB
VTRS
Price
$64.77
$16.95
Analyst Decision
Hold
Buy
Analyst Count
17
4
Target Price
$69.35
$13.50
AVG Volume (30 Days)
2.5M
8.5M
Earning Date
05-01-2026
05-07-2026
Dividend Yield
3.77%
3.21%
EPS Growth
N/A
N/A
EPS
2.10
0.05
Revenue
$30,153,000,000.00
$14,299,900,000.00
Revenue This Year
$5.55
$4.41
Revenue Next Year
N/A
$1.96
P/E Ratio
$30.93
$340.10
Revenue Growth
N/A
N/A
52 Week Low
$41.58
$9.43
52 Week High
$83.94
$18.39

Technical Indicators

Market Signals
Indicator
LYB
VTRS
Relative Strength Index (RSI) 54.66 55.54
Support Level $61.48 $15.84
Resistance Level $68.52 $17.17
Average True Range (ATR) 1.95 0.39
MACD -0.05 0.07
Stochastic Oscillator 45.49 75.62

Price Performance

Historical Comparison
LYB
VTRS

About LYB LyondellBasell Industries NV (Netherlands)

LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: